Clinical Trials
28 trialsNCT05366881 2026-01-20
CAMPERR
Adela, Inc
Recruiting
NCT03342144 2025-12-08
VeRVe
AbbVie
Recruiting
NCT03452774 2025-10-28
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
Recruiting
NCT05309733 2025-07-29
A Long-term Follow-up Study of Patients Who Received VOR33
Vor Biopharma
Terminated
NCT05179824 2025-05-06
Tempus Priority Study: A Pan-tumor Observational Study
Tempus AI
Active not recruiting
NCT05282108 2025-03-26
CARCML
Hikma Pharmaceuticals LLC
Recruiting
NCT04466059 2024-12-17
BELUGA
Munich Leukemia Laboratory
Recruiting
NCT05046444 2024-12-17
SIRIUS
Munich Leukemia Laboratory
Recruiting
NCT04014374 2024-07-24
Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab
Kyowa Kirin Co., Ltd.
Recruiting
NCT05635266 2024-05-07
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Sanguine Biosciences
Recruiting
NCT01931644 2024-04-18
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions
Sanguine Biosciences
Completed
NCT02455024 2024-04-04
OMNI
Takeda
Terminated
NCT05032339 2023-10-30
Evaluation of the Plasma Cell Disorders Panel on the BD FACSLyric™ Flow Cytometer
Becton, Dickinson and Company
Completed
NCT05743465 2023-03-02
A Study to Evaluate Available Treatment Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and Nilotinib in Adults With Chronic Myeloid Leukemia
Takeda
Completed
NCT02921815 2022-06-14
A Study to Analyze the Occurrence of Transformation From Myelodysplastic Syndrome to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndrome Who Received Revlimid® 5 mg Capsules and Who Are Continuing or no Longer Continuing Revlimid Treatment
Celgene
Completed
NCT03454503 2021-02-23
Effectiveness and Safety Study of Generic Imatinib in Chronic Myeloid Leukemia Patients in Egypt
Hikma Pharmaceuticals LLC
Completed
NCT02303522 2020-05-06
Historical Data Analysis of Complete Remission in Children With R/R Acute Lymphoblastic Leukemia (ALL)
Amgen
Completed
NCT02085798 2020-01-27
Health Outcomes of Recently Diagnosed Myelodysplastic Syndrome (MDS)/Chronic Myelomonocytic Leukemia (CMML) Patients Depending on Treatment Strategy (Wait and See, Support, Active Treatment)
Celgene
Completed
NCT03099031 2019-12-16
PREDICARE
LEO Pharma
Completed
NCT02891551 2019-07-24
OCEAN
Celgene
Completed
NCT02546791 2017-07-26
PASS
Bristol-Myers Squibb
Completed
NCT01254318 2016-11-02
TRAFIC
Merck Sharp & Dohme LLC
Completed
NCT01188278 2016-09-30
Treatment With Second Generation Tyrosine Kinase Inhibitors (2G TKI) Post Imatinib Failure Survey
Bristol-Myers Squibb
Completed
NCT02559583 2016-07-20
HOLA
Janssen-Cilag Ltd.
Completed
NCT01739491 2015-12-02
A Study of Safety and Effectiveness of Bendamustine Hydrochloride in Adult Filipino Patients With Chronic Lymphocytic Leukemia
Janssen Pharmaceutica
Withdrawn
NCT02016833 2015-04-30
Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity
PX Biosolutions
Completed
NCT00195533 2009-11-16
Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients
Wyeth is now a wholly owned subsidiary of Pfizer
Completed
NCT00161668 2007-03-15
Study Evaluating Mylotarg (Gemtuzumab Ozogamicin) in Usual Care
Wyeth is now a wholly owned subsidiary of Pfizer
Completed